Target discovered that halts osteoarthritis-type knee cartilage degeneration

ADA lowers target HbA1C levels for children with type 1 diabetes
15 January 2021
Researchers find NTRK fusions more common than expected in pediatric tumors
15 January 2021

Target discovered that halts osteoarthritis-type knee cartilage degeneration

There is currently no cure for osteoarthritis, but a group of scientists believe they’ve discovered a method through which a simple knee injection could potentially stop the disease’s effects. These researchers showed that they could target a specific protein pathway in mice, put it into overdrive and halt cartilage degeneration over time. Building on that finding, they were able to show that treating mice with surgery-induced knee cartilage degeneration through the same pathway via the state of the art of nanomedicine could dramatically reduce the cartilage degeneration and knee pain. These findings were published in Science Translational Medicine.

Comments are closed.